mafosfamide has been researched along with Colorectal Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coomber, BL; Rak, JW; Sasazuki, T; Shahrzad, S; Shirasawa, S | 1 |
| Bernhardt, C; Coerper, C; Golbach, G; Klein, HO; Voigt, P | 1 |
| Berger, MR; Garzon, F; Petru, E; Salas, M; Schmähl, D; Schwulera, U | 1 |
1 trial(s) available for mafosfamide and Colorectal Neoplasms
| Article | Year |
|---|---|
Combination of interferons and cytostatic drugs for treatment of advanced colorectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Cyclophosphamide; Drug Evaluation; Female; Humans; Ifosfamide; Interferon-beta; Interferon-gamma; Male; Middle Aged; Recombinant Proteins; Remission Induction | 1991 |
2 other study(ies) available for mafosfamide and Colorectal Neoplasms
| Article | Year |
|---|---|
Low-dose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenografts.
Topics: Angiogenesis Inhibitors; Animals; Cell Hypoxia; Cell Line, Tumor; Colorectal Neoplasms; Cyclophosphamide; Genes, ras; Humans; Mice; Mutation; Neoplasm Transplantation; Transplantation, Heterologous | 2008 |
Treatment of chemically induced autochthonous rat mammary and colorectal carcinomas with interleukin-2.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinogens; Colorectal Neoplasms; Cyclophosphamide; Dimethylnitrosamine; Female; Interleukin-2; Male; Mammary Neoplasms, Experimental; Methylnitrosourea; Neoplasm Transplantation; Rats; Rats, Inbred Strains | 1991 |